Reversion of Pneumolysin-Induced Executioner Caspase Activation Redirects Cells to Survival.
Streptococcus pneumonia
apoptosis
calcium
cell survival
mitochondria
pneumolysin
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
04 06 2021
04 06 2021
Historique:
received:
07
07
2020
accepted:
06
10
2020
pubmed:
13
10
2020
medline:
12
2
2022
entrez:
12
10
2020
Statut:
ppublish
Résumé
Apoptosis is an indispensable mechanism for eliminating infected cells and activation of executioner caspases is considered to be a point of no return. Streptococcus pneumoniae, the most common bacterial pathogen causing community-acquired pneumonia, induces apoptosis via its pore-forming toxin pneumolysin, leading to rapid influxes of mitochondrial calcium [Ca2+]m as well as fragmentation, and loss of motility and membrane potential, which is accompanied by caspase-3/7 activation. Using machine-learning and quantitative live-cell microscopy, we identified a significant number of alveolar epithelial cells surviving such executioner caspase activation after pneumolysin attack. Precise single-cell analysis revealed the [Ca2+]m amplitude and efflux rate as decisive parameters for survival and death, which was verified by pharmacological inhibition of [Ca2+]m efflux shifting the surviving cells towards the dying fraction. Taken together, we identified the regulation of [Ca2+]m as critical for controlling the cellular fate under pneumolysin attack, which might be useful for therapeutic intervention during pneumococcal infection.
Identifiants
pubmed: 33045080
pii: 5921162
doi: 10.1093/infdis/jiaa639
doi:
Substances chimiques
Bacterial Proteins
0
Streptolysins
0
plY protein, Streptococcus pneumoniae
0
Caspases
EC 3.4.22.-
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1973-1983Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.